Lucie Kutikova

Lucie Kutikova, PhD, currently serves as the Global Senior Director of Real World Evidence & HEOR at Novavax, a position held since September 2022. Prior to this, Lucie worked at GSK as the Global Market Access Director in Global Market Access and Pricing from June 2020 to August 2022. Lucie’s extensive experience in health economics and reimbursement spans over a decade at Amgen, where Lucie was the Director of Health Economics and Reimbursement for Europe, Australia, and emerging markets from October 2009 to May 2020. Additional roles include Associate Director of Access/Health Economics at Bristol-Myers Squibb from August 2006 to September 2009 and Global Health Outcomes Scientist at Eli Lilly and Company from August 2001 to July 2006. Lucie holds a PhD in Health Science Administration/Health Services Research from The University of Tennessee Health Science Center and an MS in Pharmacy from Charles University.